Tradestie Institutional Equity Comparison Engine
VKTX vs XNCR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XNCR Overall Edge
XNCR Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Valuation, Momentum & Technical, Options & Structure while VKTX counters with relative strength in Growth & Margin. Fundamentally, VKTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus XNCR at 68.0x Forward P/E and -72.7% operating margin (+454.9% YoY). In options structure, VKTX sits in BREAKDOWN (88th %ile IV; Dealer Gamma Walls on Pro) against XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
XNCR
VKTX N/M vs XNCR 68.0x Fwd P/E
Growth & Margin Winner
VKTX
Op Margin 0.0% vs -72.7% ยท YoY +0.0% vs +454.9%
Momentum & Technical Winner
XNCR
1Y -31.1% vs +154.5% ยท 52W Pos 16% vs 84%
Options & Structure Winner
XNCR
BREAKDOWN (88th %ile IV) vs BREAKOUT (10th %ile IV)
VKTX
NASDAQ
Viking Therapeutics, Inc
Pharmaceutical Preparations
$26.86
-8.08% 1D
Market Cap
$3.8B
1M Return
+6.71%
1Y Return
-31.13%
Forward P/E
N/M
Unified AI Score
46.5 / 100
HOLD
Tech 45.0
Fund 53.0
Flow 71.0
Mom 54.0
XNCR
NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.61
-3.99% 1D
Market Cap
$2.9B
1M Return
+55.84%
1Y Return
+154.54%
Forward P/E
68.0x
Unified AI Score
29.6 / 100
SELL
Tech 50.0
Fund 32.0
Flow 66.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VKTX -31.13%
XNCR +154.54%
Spread: +185.67 pp (XNCR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VKTX TTM Op. Margin: 0.0%
XNCR TTM Op. Margin: -72.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VKTX vs XNCR. Trailing 12-month operating profitability (VKTX 0.0% vs XNCR -72.7%) and valuation multiples (VKTX N/M vs XNCR 68.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VKTX | XNCR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.8B | $2.9B | Larger Scale | VKTX |
| Trailing P/E Ratio Valuation | N/M | 68.0x | Lower Multiple | XNCR |
| Forward P/E Ratio Valuation | N/M | 68.0x | Lower Multiple | XNCR |
| Revenue Growth (YoY) Growth | +0.0% | +454.9% | Higher Growth | XNCR |
| Operating Margin (TTM) Profitability | 0.0% | -72.7% | Higher Margin | VKTX |
| Net Profit Margin Profitability | 0.0% | -58.8% | Higher Margin | VKTX |
| Return on Equity (ROE) Capital Efficiency | -96.4% | -19.9% | Higher ROE | XNCR |
| 52-Week Range Position Momentum | 16% ($24โ$43) | 84% ($10โ$41) | Stronger Trend | XNCR |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 74% Vol | 1.21ฮฒ ยท 87% Vol | Lower Realized Risk | VKTX |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 29.6 / 100 (SELL) | Higher Composite | VKTX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VKTX vs XNCR Buy Guide
VKTX
BREAKDOWN
93d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
88th %ile
IV Regime
Extreme (>80th %ile)
XNCR
BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VKTX nor XNCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.